Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Alx Oncology Holdings Inc (ALXO)

Alx Oncology Holdings Inc (ALXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Alx Oncology Holdings Inc 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 USA

www.alxoncology.com Employees: 72 P: 650-466-7125

Description:

ALX Oncology Holdings Inc.is a clinical-stage immuno-oncology company. It focuses on developing therapies for patients fighting cancer. The company's product candidate consist ALX148, which is in clinical stage. ALX Oncology Holdings Inc.is based in Burlingame, California.

Key Statistics

Overview:

Market Capitalization, $K 68,038
Enterprise Value, $K 55,268
Shares Outstanding, K 52,743
Annual Sales, $ 0 K
Annual Net Income, $ -160,810 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -30,710 K
EBIT, $ -159,880 K
EBITDA, $ -165,280 K
60-Month Beta 1.03
% of Insider Shareholders 33.40%
% of Institutional Shareholders 97.97%
Float, K 35,127
% Float 66.60%
Short Volume Ratio 0.58

Growth:

1-Year Return -87.00%
3-Year Return -96.63%
5-Year Return 0.00%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.58 on 11/07/24
Next Earnings Date 11/11/24
Earnings Per Share ttm -2.98
EPS Growth vs. Prev Qtr 23.68%
EPS Growth vs. Prev Year 53.23%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ALXO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -93.02%
Return-on-Assets % -70.67%
Profit Margin % 0.00%
Debt/Equity 0.07
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.51
Book Value/Share 2.60
Interest Coverage -101.43
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar